9,529 Shares in Celcuity Inc. (NASDAQ:CELC) Acquired by SG Americas Securities LLC

SG Americas Securities LLC purchased a new stake in shares of Celcuity Inc. (NASDAQ:CELC) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 9,529 shares of the company’s stock, valued at approximately $139,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Barclays PLC bought a new position in Celcuity during the 2nd quarter valued at $37,000. Pale Fire Capital SE bought a new position in Celcuity during the 3rd quarter valued at $95,000. Royal Bank of Canada boosted its stake in Celcuity by 33.4% during the 2nd quarter. Royal Bank of Canada now owns 9,674 shares of the company’s stock valued at $107,000 after purchasing an additional 2,424 shares in the last quarter. MetLife Investment Management LLC bought a new position in Celcuity during the 2nd quarter valued at $101,000. Finally, Bank of America Corp DE lifted its position in shares of Celcuity by 138.3% during the 1st quarter. Bank of America Corp DE now owns 7,527 shares of the company’s stock valued at $77,000 after acquiring an additional 4,368 shares during the last quarter. 63.33% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. HC Wainwright reiterated a “buy” rating and set a $27.00 price objective on shares of Celcuity in a research report on Thursday, March 28th. Craig Hallum increased their price objective on Celcuity from $20.00 to $25.00 and gave the company a “buy” rating in a research report on Thursday, March 28th. Stifel Nicolaus assumed coverage on Celcuity in a research report on Thursday, February 22nd. They set a “buy” rating and a $40.00 price objective for the company. Finally, Needham & Company LLC reiterated a “buy” rating and set a $24.00 price objective on shares of Celcuity in a research report on Friday, April 12th.

Celcuity Price Performance

CELC opened at $17.23 on Wednesday. The stock has a fifty day moving average of $17.47 and a 200-day moving average of $14.46. The firm has a market capitalization of $524.65 million, a P/E ratio of -6.41 and a beta of 0.78. Celcuity Inc. has a 12-month low of $8.39 and a 12-month high of $22.19. The company has a quick ratio of 13.43, a current ratio of 13.43 and a debt-to-equity ratio of 0.26.

About Celcuity

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.